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Recommendations
There is no evidence that conflicts with the previous 
recommendations published in the original version of the 
“Guidelines for the performance of fusion procedures for 
degenerative disease of the lumbar spine.”
Grade B
It is recommended that when assessing functional 
outcome in patients treated for low-back pain due to de-
generative disease, a reliable, valid, and responsive out-
comes instrument, such as the disease-specific Oswestry 
Disability Index (ODI), be used (Level II evidence).
It is recommended that when assessing general 
health-related quality of life (HR-QOL) in patients treat-
ed for low-back pain due to degenerative disease that a 
reliable, valid, and responsive outcomes instrument, such 
as the 36-Item Short Form Health Survey (SF-36), be used 
(Level II evidence).
Guideline update for the performance of fusion procedures 
for degenerative disease of the lumbar spine. Part 2:  
Assessment of functional outcome following lumbar fusion
Zoher GhoGawala, M.D.,1 Daniel K. resnicK, M.D.,2 williaM c. watters iii, M.D.,3 
Praveen v. MuMManeni, M.D.,4 anDrew t. Dailey, M.D.,5 tanvir F. chouDhri, M.D.,6  
Jason c. ecK, D.o., M.s.,7 aloK sharan, M.D.,8 Michael w. GroFF, M.D.,9  
JeFFrey c. wanG, M.D.,10 sanJay s. Dhall, M.D.,4 anD Michael G. Kaiser, M.D.11
1Alan and Jacqueline Stuart Spine Research Center, Department of Neurosurgery, Lahey Clinic, Burlington, 
and Tufts University School of Medicine, Boston, Massachusetts; 2Department of Neurosurgery, University of 
Wisconsin, Madison, Wisconsin; 3Bone and Joint Clinic of Houston, Texas; 4Department of Neurological  
Surgery, University of California, San Francisco, California; 5Department of Neurosurgery, University of 
Utah, Salt Lake City, Utah; 6Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New 
York, New York; 7Center for Sports Medicine and Orthopaedics, Chattanooga, Tennessee; 8Department of 
Orthopaedic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York; 
9Department of Neurosurgery, Brigham and Women’s Hospital, Boston, Massachusetts; 10Department of  
Orthopaedic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California; 
and 11Department of Neurosurgery, Columbia University, New York, New York
Assessment of functional patient-reported outcome following lumbar spinal fusion continues to be essential for 
comparing the effectiveness of different treatments for patients presenting with degenerative disease of the lumbar 
spine. When assessing functional outcome in patients being treated with lumbar spinal fusion, a reliable, valid, and 
responsive outcomes instrument such as the Oswestry Disability Index should be used. The SF-36 and the SF-12 
have emerged as dominant measures of general health-related quality of life. Research has established the minimum 
clinically important difference for major functional outcomes measures, and this should be considered when assess-
ing clinical outcome. The results of recent studies suggest that a patient’s pretreatment psychological state is a major 
independent variable that affects the ability to detect change in functional outcome.
(http://thejns.org/doi/abs/10.3171/2014.4.SPINE14258)
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ponent summary; RMDQ = Roland-Morris Disability Question-
naire; ROC = receiver operating characteristic; SF-12 = 12-Item 
Short Form Health Survey; SF-36 = 36-Item Short Form Health 
Survey; SIP = Sickness Impact Profile; SRS-22 = 22-Item Scoliosis 
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It is recommended that the minimum clinically im-
portant difference (MCID) be considered when assessing 
clinical outcome (Level II evidence).
Rationale
The assessment of functional outcome for patients 
who undergo lumbar fusion surgery continues to be an 
area of intense clinical interest. The Institute of Medicine 
has identified low-back pain treatment options as one of 
the highest priorities for new comparative effectiveness re-
search.11 In an effort to improve the reporting of outcomes 
following lumbar fusion, an emphasis has been placed on 
the implementation of valid, reliable, and objective out-
come measures. The majority of these instruments are pa-
tient self-assessment questionnaires that report quality of 
life. They can be divided into 2 groups: those that seek to 
measure disease-specific outcomes, such as the ODI, and 
general health surveys, such as the SF-36.
The original Lumbar Fusion Guidelines recommend-
ed the utilization of reliable, valid, and responsive instru-
ments to assess clinical outcome following treatment for 
low-back pain; however, there was insufficient evidence to 
standardize the utilization of one instrument over another, 
and multiple options were suggested. Patient satisfaction 
scales, however, were discouraged unless no alternative 
was available. Since the publication of the first generation 
of guidelines, investigators have continued to evaluate the 
utility of these instruments in the assessment of patients 
treated for low-back pain. We have assessed functional 
outcome measures by evaluating the evidence from a di-
agnostic perspective. That is, measurement of functional 
outcome would not be expected to improve outcome per 
se, but rather should allow investigators to “diagnose” any 
improvement in outcome following treatment.
Search Criteria
A computerized search of the National Library of 
Medicine database of the literature published between 
2004 and 2011 was performed. The following subject head-
ings and configurations yielded 1297 citations: ((“Lumbo-
sacral Region”[MeSH] OR “Lumbar Vertebrae”[MeSH]) 
AND “Spinal Fusion”[MeSH]) OR “lumbar fusion”[All 
Fields] OR (“lumbar”[title] AND “fusion”[title])) AND 
(“Treatment Outcome”[MeSH] OR “Patient Sa tis fac-
tion”[MeSH] OR “functional outcome”[All Fields] OR 
“functional outcomes”[All Fields] OR “outcome”[title] 
OR “outcomes”[title]). An additional search using “lum-
bar spine surgery,” “outcomes,” and “validation studies” 
yielded an additional 11 citations. The titles and abstracts 
of the 1308 articles were reviewed, and 28 clinical series 
focusing on adult patients who underwent lumbar fusion 
procedures were selected for analysis. Among the ar-
ticles reviewed from this search, 10 have been included 
in the evidentiary table (see Table 1) along with 5 major 
articles (Level II evidence) from the original Lumbar Fu-
sion Guidelines.17 These 15 articles form the basis for these 
recommendations. Two studies focused on the reliability 
of new outcome measures. Four studies examined the reli-
ability, validity, and responsiveness of a new lumbar spine 
outcomes measure. Four additional studies focused on the 
validity of established lumbar spine outcome measures, 1 
study examined the responsiveness of a specific outcome 
measure, and 1 study calculated MCIDs for 4 major lum-
bar spine outcome measures. Three studies reported major 
predictors of functional outcome for lumbar spine patients. 
Among the 15 studies, 14 studies provided Level II and 1 
study provided Level III medical evidence regarding func-
tional outcome measures from a diagnostic perspective.
Scientific Foundation
Characteristics of a Functional Outcome Instrument
The criteria that determine whether a functional out-
come instrument appropriately measures the response to 
treatment have not changed since the publication of the 
original guidelines in 2005.17 The accuracy of an outcome 
instrument is dependent on 3 qualities—reliability, validi-
ty, and responsiveness.6,7,13 Reliability is the measure of an 
instrument’s consistency or reproducibility when report-
ing observations and is described by the following char-
acteristics: interobserver reliability (the degree to which 
different observers obtain similar results when measur-
ing the same phenomenon), intraobserver reliability (the 
extent to which the same observer obtains similar results 
on repeated observations of a fixed characteristic), test-
retest reliability (consistency of an instrument between 2 
separate time points, similar to intraobserver reliability, 
except that the characteristic, if clinical, may change with 
time), and internal consistency (used to describe the ex-
tent to which individual test domains correlate with the 
composite result).12
Reliability of an instrument is measured statistically 
in a variety of ways, depending on the nature of the re-
cording of the observation: the k statistic measures agree-
ment between observers or observations beyond chance 
when the measure is in the form of categorical data, phi 
is used with dichotomous data, and intraclass correlation 
coefficient (ICC) is used with continuous data (and can be 
used with categorical data). In addition, the a statistic is 
used to measure internal consistency—the degree to which 
individual aspects (called “domains”) of an outcome mea-
sure correlate with the composite result. A functional out-
come measure is considered highly reliable if the k value 
is greater than 0.8. A measure is thought to be moderately 
reliable if the k value is between 0.6 and 0.8. A k value 
of less than 0.6 suggests that the outcome measure is less 
reliable.10 The internal reliability (a) is generally measured 
using the Cronbach a test to determine whether individual 
domains of a test correlate with the final composite result.4
The second criterion used to evaluate a functional 
outcome measure is validity, the ability to measure the 
disease-specific properties of interest. More recent lit-
erature compares novel functional outcome measures 
with previously validated instruments to assess validity.15 
Typically, the Pearson product-moment coefficient of cor-
relation (r) is used to examine the congruency between 
one outcome measure and another, with r > 0.80 repre-
senting a strong correlation between measures.14 Newer 
measures, such as the 22-Item Scoliosis Research Soci-
Part 2: Assessment of functional outcome following lumbar fusion
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ety questionnaire (SRS-22), the Balanced Inventory for 
Spinal Disorders (BIS), and the Lumbar Spine Outcomes 
Questionnaire (LSOQ) were compared with the ODI and 
SF-36, since both of these have been shown to be reliable, 
valid, and responsive for patients with lumbar degenera-
tive diseases who are undergoing lumbar fusion. How-
ever, this is not a direct measure of validity.
Finally, a functional outcome instrument must be re-
sponsive. The instrument must be able to detect differ-
ences in disease severity among populations and should 
be able to measure the magnitude of treatment effect.
Summary of Literature From Previous Guidelines
Fairbank and colleagues showed that the ODI is a re-
liable, valid, and responsive measure for detecting chang-
es in low-back pain and its functional severity.8 Roland 
and Morris demonstrated the Roland-Morris Disability 
Questionnaire (RMDQ) is a reliable assessment of acute 
low-back pain.18 Deyo showed the Sickness Impact Pro-
file (SIP) and the modified RMDQ are reliable for the 
assessment of low-back pain, which appears to follow the 
physical dimension of functional disability.5 Salén et al. 
found the Disability Rating Index (DRI) to be a reliable, 
valid, and responsive measure in patients with axial skel-
etal pain (see Table 1).19
Minimum Clinically Important Difference
The validation of functional outcome measures al-
lows the researcher to confidently select appropriate tools 
for clinical studies. In order for clinicians to interpret the 
relevant changes in a particular outcome score, it is im-
portant to define the minimum change that is clinically 
meaningful. Copay and colleagues performed a rigor-
ous study of 460 patients where preoperative and 1-year 
postoperative scores were obtained in 454 patients with 
99% follow-up.3 The authors determined the MCID for 
the ODI (12.8 points), SF-36 physical component sum-
mary (PCS) (4.9 points), visual analog scale (VAS) for 
back pain (1.2 points), and VAS for leg pain (1.6 points). 
The study used robust and validated techniques to pro-
vide Level II evidence (see Table 1).3
General Health-Related Quality-of-Life Measures
Lee et al. performed a study of 98 patients scheduled 
for either lumbar or cervical spine surgery and compared 
the 12-Item Short Form Health Survey (SF-12, version 2) 
to the SF-36 (version 2).14 The physical and mental com-
ponent summary scores strongly correlated between SF-
12 and SF-36: r ranged between 0.88 and 0.97. Except 
for general health, most of the other subscales correlated 
strongly (r range 0.81–0.99). This study provides Level II 
evidence that the SF-12 (version 2) is a valid alternative 
for the SF-36 for patients with lumbar spinal disorders.14 
This is important because of a substantial decrease in the 
amount of time necessary for eliciting responses on the 
part of patients by utilization of the SF-12 rather than the 
SF-36 (see Table 1).
Guilfoyle et al. performed an outcome study of 620 
unselected patients who underwent either cervical or 
lumbar spinal surgery for degenerative disease.9 The SF-
36 was compared with a wide range of disease-specific 
outcome measures to determine the utility of a general 
health-related quality of life (HR-QOL) instrument for 
assessing functional outcome for patients with degenera-
tive spinal diseases. There was excellent early follow-up 
(88% at 3 months) and a modest loss at long-term fol-
low-up (74% available for follow-up at 1–5 years). The 
SF-36 physical function, bodily pain, general health, vi-
tality, and mental health domains were free from ceiling 
or floor effects that would skew the results. In addition, 
the physical function and bodily pain domains correlated 
well with validated disease-specific outcome measures. 
Bodily pain correlated well with VAS arm or leg scores, 
and the mental health domain correlated well to validated 
psychological morbidity assessments. The SF-36 physi-
cal function and bodily pain domains demonstrated good 
responsiveness (standard response mean 1.04–1.72 for 
physical function and bodily pain) following surgery for 
lumbar disorders. The authors concluded, based on Level 
II evidence, that the SF-36 was reliable, valid, and respon-
sive for measuring outcome following lumbar spinal sur-
gery (see Table 1).9
Walsh et al. assessed outcome at 3 months in 970 
patients undergoing a variety of treatments for lumbar 
degenerative disorders and compared the responsiveness 
of disease-specific and general health outcome instru-
ments.23 In this study cohort, 27% of patients underwent 
surgery, while most were treated with various nonopera-
tive therapies. The authors used a diagnostic test para-
digm, the receiver operating characteristic (ROC), for 
assessing the responsiveness of the different outcome 
measures. The “gold standard” measure of clinical im-
provement was physician-patient consensus. Patients did 
not complete this portion of the assessment 62% of the 
time, and therefore the level of evidence was downgraded 
one level for the purposes of establishing recommenda-
tions. The bodily pain, physical function, and PCS scores 
of the SF-36 compared favorably to the ODI. In general, 
all outcome measures were more responsive for assess-
ing changes in pain than changes in function. The au-
thors provided Level II evidence that the SF-36 is both 
valid and responsive for assessing lumbar spinal pain and 
functional outcomes and that it might not be necessary to 
include disease-specific outcome measures in all studies 
when using the SF-36 (see Table 1).23
Pahl et al. extended the observation that the SF-36 is 
valid for assessing lumbar spinal disorders by performing 
a cross-sectional assessment of 4442 patients with spinal 
problems.16 The data were generated from the National 
Spine Network database which consisted of 11,029 pa-
tients. The extent of patient follow-up is not stated, and 
the statistical methods for handling missing data were 
not discussed. The study’s level of evidence was therefore 
downgraded by one level. These authors found that the 
impact on patients with lumbar herniated disc with ra-
diculopathy, lumbar stenosis, lumbar degenerative spon-
dylolisthesis, or painful degenerative lumbar spondylotic 
disc disease was negative in all 8 subscales of the SF-36. 
Younger patients (< 60 years) and patients with lumbar 
disc herniation with radiculopathy had the greatest nega-
tive impact on physical health as measured by the SF-36. 
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The authors provided Level II evidence to expand the va-
lidity of the SF-36 outcome measure to include patients 
with lumbar spinal disorders for which surgery is recom-
mended (see Table 1).
Psychosocial Impact on Functional Outcome
Trief et al. explored the effect of a patient’s emotional 
state on functional outcomes following intervention for 
lumbar spinal disease.22 In a study comprising 160 pa-
tients from 2 separate lumbar fusion prospective trials, 
the authors obtained follow-up in 115 patients (72%) at 
2 years after surgery. They found that the preoperative 
SF-36 mental component summary (MCS) score was an 
independent predictor of postoperative ODI score. Spe-
cifically, patients with greater emotional morbidity preop-
eratively had less improvement in ODI following surgery 
compared with patients with more normal MCS scores 
(Level II evidence).22
Slover et al. made similar observations from a much 
larger cohort of patients.20 In a study of 3482 patients 
who underwent lumbar spinal surgery, the authors found 
that psychosocial (litigation, chronic headaches, etc.) and 
medical comorbidities reduced the responsiveness of SF-
36 and ODI.20 The authors’ conclusions regarding the ef-
fect of psychosocial comorbidities are considered Level II 
evidence since the rate of follow-up is not stated for this 
large cohort of patients (see Table 1).
Recently Validated Functional Outcome Measures
It is beyond the scope of the current Guideline Up-
date to provide a comprehensive list of all validated out-
comes measures used to evaluate patients with lumbar 
degenerative diseases. A review of the recent literature, 
however, did identify 3 relatively novel outcome tools 
that may prove useful for future outcomes analysis: the 
Lumbar Spine Outcomes Questionnaire (LSOQ),1 the 
Balanced Inventory for Spinal Disorders (BIS),21 and the 
Scoliosis Research Society-22 (SRS-22).2 The LSOQ was 
found to have an ICC greater than 0.8, was validated by 
comparing it with the ODI and SF-36 (coefficients of cor-
relation were between 0.7 and 0.9), and was found to be 
responsive (observed effect sizes ranged from 0.68 to 1.17 
for 24-month change scores).1 These data provide Level II 
evidence in support of the LSOQ (see Table 1).
The studies evaluating the BIS and SRS-22 were not 
as comprehensive as those for the LSOQ. The BIS was 
found to be valid when compared with other outcomes 
instruments, including the ODI, SF-36, and EQ-5D, but 
reliability and responsiveness were not reported.21 The 
SRS-22 was found to be more responsive than SF-12 or 
ODI for patients with lumbar degenerative scoliosis who 
underwent surgical management (Table 1).2
Summary
Since the publication of the first generation of lumbar 
spinal fusion guidelines in 2005, there have been no data 
that conflict with the previous recommendations. The 
ODI has emerged as a dominant disease-specific outcome 
measure. The SF-36 and more recently the SF-12 have 
emerged as dominant general health outcome measures. 
In some studies, there are data to suggest that the SF-36 
might be sufficient for measuring functional outcome fol-
lowing lumbar spinal fusion because it has demonstrated 
equivalent responsiveness and validity with disease-spe-
cific measures.
More novel outcome measures have been compared 
with the ODI and the SF-36 to determine their validity 
and responsiveness. Recent data demonstrate the impor-
tance of a patient’s pretreatment psychological state as 
a major independent variable that affects the ability to 
detect change in functional outcome measures—no sur-
prise to experienced spinal surgeons. Finally, research 
has established the MCID in major functional outcomes 
measures, which will enhance the interpretation of these 
observations. This information will undoubtedly guide 
future comparative-effectiveness research for lumbar de-
generative diseases.
Key Issues for Future Investigation
There is an increasing amount of data suggesting that 
patient-specific factors, such as pretreatment psychologi-
cal status, are relevant in the functional outcome assess-
ment following lumbar fusion. Specific diseases are as-
sociated with different baseline characteristics that may 
influence the response depending on the choice of func-
tional outcome measure. The SRS-22, for example, ap-
pears to be more responsive than the ODI or the SF-36 for 
evaluating the results of lumbar spinal fusion in patients 
with degenerative scoliosis.2 Establishing whether vari-
ous functional measures are better suited to assess clini-
cal outcome for a specific degenerative spine disorder 
will be an important step in the evolution of functional 
outcome assessment.
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